Science

Homer-3 autoimmunity: Insights from a newly identified case

A new case of Homer-3 autoimmunity has been described, expanding the still limited body of knowledge about this rare autoimmune cerebellar disorder. The case was reported in the Journal of Neuroimmunology in a collaboration between Euroimmun and Mayo Clinic (USA). What’s known so far To date, only 15 cases of Homer-3 autoantibody-associated disease have been […]

Company

New e-mail addresses for all Euroimmun employees

Following the successful launch of our new design last summer, another change at Euroimmun and IDS takes place, which makes our affiliation to Revvity, Inc. more visible. As part of our strategic development, we are consolidating the technical systems of our three companies. This will enable us to provide an even better service thanks to

Science

Anti-ITPR1 autoimmunity – a case mimicking Alzheimer’s disease

Autoimmunity targeting inositol 1,4,5-triphosphate receptor type 1 (ITPR1) was identified as a potential cause of cognitive decline resembling Alzheimer’s disease in a retrospective case study. The findings were reported by a research group from Norway and Germany in collaboration with Euroimmun. Patient with acute deterioration The study describes a 58-year-old patient who presented with acute

Science

High concordance of serological methods for EBV staging

A new collaborative study by Euroimmun and researchers in Türkiye reports that both ELISA and immunoblot show excellent agreement with the reference standard — indirect immunofluorescence assay (IFA) — for serological staging of Epstein-Barr virus (EBV) infections. A widespread infection EBV is a ubiquitous herpesvirus that infects more than 95% of the global population, usually

Scroll to Top